These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31433058)

  • 1. A longitudinal analysis of albendazole treatment effect on neurocysticercosis cyst evolution using multistate models.
    Montgomery MA; Ramos M; Kelvin EA; Carpio A; Jaramillo A; Hauser WA; Zhang H
    Trans R Soc Trop Med Hyg; 2019 Dec; 113(12):781-788. PubMed ID: 31433058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthelmintics for people with neurocysticercosis.
    Monk EJM; Abba K; Ranganathan LN
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD000215. PubMed ID: 34060667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.
    Garcia HH; Lescano AG; Gonzales I; Bustos JA; Pretell EJ; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
    Clin Infect Dis; 2016 Jun; 62(11):1375-9. PubMed ID: 26984901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro analysis of albendazole sulfoxide enantiomers shows that (+)-(R)-albendazole sulfoxide is the active enantiomer against Taenia solium.
    Paredes A; de Campos Lourenço T; Marzal M; Rivera A; Dorny P; Mahanty S; Guerra-Giraldez C; García HH; Nash TE; Cass QB;
    Antimicrob Agents Chemother; 2013 Feb; 57(2):944-9. PubMed ID: 23229490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts.
    Proaño JV; Madrazo I; Avelar F; López-Félix B; Díaz G; Grijalva I
    N Engl J Med; 2001 Sep; 345(12):879-85. PubMed ID: 11565520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial of antiparasitic treatment for cerebral cysticercosis.
    Kumar S
    N Engl J Med; 2004 Apr; 350(16):1686-7; author reply 1686-7. PubMed ID: 15088324
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurocysticercosis with Diplopia Responds Well to Albendazole.
    Sato A; Nakamura I; Fujita H; Fukushima S; Mizuno Y; Fujii T; Matsumoto T
    Intern Med; 2016; 55(9):1219-22. PubMed ID: 27150884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.
    Garcia HH; Del Brutto OH;
    Epilepsy Behav; 2017 Nov; 76():158-162. PubMed ID: 28606690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epileptiform seizures revealing neurocysticercosis: report of two clinical cases in Libreville, Gabon.
    Okome-Nkoumou MM; Ondounda M; Dzeing-Ella A; Mounguengui D; Madjinou MI; Clevenbergh P; Magne C; Nzenze JR
    Trop Doct; 2010 Oct; 40(4):235-7. PubMed ID: 20688973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study on the treatment of severe neurocysticercosis].
    Yuan Z; Ren HJ; Ding YZ; Zhang JS; Wang WP; Wu XL; Qiu MD
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Aug; 22(4):213-7. PubMed ID: 15587154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocysticercosis: A case study of a Mongolian traveler who visited China and India with an updated review in Asia.
    Davaasuren A; Davaajav A; Ukhnaa B; Purvee A; Unurkhaan S; Luvsan A; Logan JE; Ito A
    Travel Med Infect Dis; 2017; 20():31-36. PubMed ID: 28478337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocysticercosis an uncommon intra-cerebral infection in Malaysia.
    Arasu K; Khairul A; Waran V
    Med J Malaysia; 2005 Oct; 60(4):514-6. PubMed ID: 16570721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hydrocephalus secondary to neurocysticercosis.
    Weber D; Stevens EA; Couture DE; Winslow JE
    J Emerg Med; 2012 Aug; 43(2):342-3. PubMed ID: 20630680
    [No Abstract]   [Full Text] [Related]  

  • 14. [A Histopathologically Diagnosed Neurocysticercosis Case from Türkiye].
    Özer Balin Ş; Enez M; Akbulut A; Çalık M; Akgün B; Balgetir F; Yıldırım H
    Mikrobiyol Bul; 2022 Oct; 56(4):755-762. PubMed ID: 36458721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and Determinant Factors for Calcification in Neurocysticercosis.
    Bustos JA; Arroyo G; Gilman RH; Soto-Becerra P; Gonzales I; Saavedra H; Pretell EJ; Nash TE; O'Neal SE; Del Brutto OH; Gonzalez AE; Garcia HH;
    Clin Infect Dis; 2021 Nov; 73(9):e2592-e2600. PubMed ID: 32556276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthelmintics for people with neurocysticercosis.
    Abba K; Ramaratnam S; Ranganathan LN
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD000215. PubMed ID: 20238309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthelmintics for people with neurocysticercosis.
    Abba K; Ramaratnam S; Ranganathan LN
    Cochrane Database Syst Rev; 2010 Jan; (1):CD000215. PubMed ID: 20091504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicystic tumor in the fourth ventricle: consider neurocysticercosis.
    Costa CU; von Einsiedel HG; Disko R; Berthele A
    J Neurol; 2006 Aug; 253(8):1092-3. PubMed ID: 16649100
    [No Abstract]   [Full Text] [Related]  

  • 19. Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials.
    Matthaiou DK; Panos G; Adamidi ES; Falagas ME
    PLoS Negl Trop Dis; 2008 Mar; 2(3):e194. PubMed ID: 18335068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis.
    Romo ML; Wyka K; Carpio A; Leslie D; Andrews H; Bagiella E; Hauser WA; Kelvin EA;
    Trans R Soc Trop Med Hyg; 2015 Nov; 109(11):738-46. PubMed ID: 26433183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.